Langzeiteffekte der Anti-VEGF-Therapie bei Frühgeborenenretinopathie
Author:
Publisher
Springer Science and Business Media LLC
Subject
Ophthalmology
Link
http://link.springer.com/article/10.1007/s00347-018-0700-6/fulltext.html
Reference21 articles.
1. Avery RL, Castellarin AA, Steinle NC et al (2017) Systematic pharmacokinetics and pharmacodynamics of intravitreal aflibercept, bevacizumab, and ranibizumab. Retina 37:1847–1858. https://doi.org/10.1097/IAE.0000000000001493
2. Chen S‑N, Lian I, Hwang Y‑C et al (2015) Intravitreal anti-vascular endothelial growth factor treatment for retinopathy of prematurity: comparison between ranibizumab and bevacizumab. Retina 35:667–674. https://doi.org/10.1097/IAE.0000000000000380
3. Chen W, Binenbaum G, Karp K et al (2014) Late recurrence of retinopathy of prematurity after treatment with both intravitreal bevacizumab and laser. J Aapos 18:402–404. https://doi.org/10.1016/j.jaapos.2014.03.011
4. Garcia-Valenzuela E, Kaufman LM (2005) High myopia associated with retinopathy of prematurity is primarily lenticular. J Aapos 9:121–128. https://doi.org/10.1016/j.jaapos.2004.12.018
5. Geloneck MM, Chuang AZ, Clark WL et al (2014) Refractive outcomes following bevacizumab monotherapy compared with conventional laser treatment: a randomized clinical trial. JAMA Ophthalmol 132:1327–1333. https://doi.org/10.1001/jamaophthalmol.2014.2772
Cited by 4 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Mechanistic insights into the alterations and regulation of the AKT signaling pathway in diabetic retinopathy;Cell Death Discovery;2023-11-17
2. Overexpression of Twist1 in vascular endothelial cells promotes pathological retinal angiogenesis in mice;Zoological Research;2022
3. Hypoxia-induced retinal pigment epithelium cell-derived bFGF promotes the migration and angiogenesis of HUVECs through regulating TGF-β1/smad2/3 pathway;Gene;2021-07
4. Ranibizumab in retinopathy of prematurity – one‐year follow‐up of ophthalmic outcomes and two‐year follow‐up of neurodevelopmental outcomes from the CARE‐ROP study;Acta Ophthalmologica;2021-03-19
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3